JAGUAR HEALTH, INC. Amortization of Debt Issuance Costs and Discounts
JAGUAR HEALTH, INC. (JAGX) reported Amortization of Debt Issuance Costs and Discounts of $153.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-04-07
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-03-31 was $274.00K, a 78.53% decline year-over-year.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $153.00K, a 44.16% decline from fiscal 2024.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $274.00K, a 97.93% decline from fiscal 2023.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $13.21M, a 12.32% increase from fiscal 2022.
- JAGUAR HEALTH, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $11.76M, a 127.38% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $153.00K 10-K · filed 2026-04-07 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | $0.00 derived: sum of 3 quarters · filed 2026-04-07 | $274.00K 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $274.00K 10-Q · filed 2025-11-14 | $1.98M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $274.00K 10-Q · filed 2025-08-14 | $1.98M derived: sum of 3 quarters · filed 2025-08-14 | $9.07M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $274.00K 10-Q · filed 2025-05-15 | $1.98M derived: sum of 2 quarters · filed 2025-05-15 | $9.07M derived: sum of 3 quarters · filed 2025-05-15 | $12.20M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $8.80M derived: sum of 2 quarters · filed 2025-03-31 | $11.93M derived: sum of 3 quarters · filed 2025-03-31 | $13.21M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $7.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $10.22M derived: sum of 2 quarters · filed 2024-11-13 | $11.50M 10-Q · filed 2024-11-13 | $14.46M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.41M 10-Q · filed 2024-08-13 | $7.38M derived: sum of 3 quarters · filed 2024-08-13 | $9.90M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $1.28M 10-Q · filed 2024-05-14 | $4.24M derived: sum of 2 quarters · filed 2024-05-14 | $6.77M derived: sum of 3 quarters · filed 2024-05-14 | $9.61M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.50M derived: sum of 2 quarters · filed 2024-04-01 | $8.33M derived: sum of 3 quarters · filed 2024-04-01 | $11.76M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $5.36M derived: sum of 2 quarters · filed 2023-11-14 | $8.79M 10-Q · filed 2023-11-14 | $10.33M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $6.26M 10-Q · filed 2023-08-14 | $7.80M derived: sum of 3 quarters · filed 2023-08-14 | $9.00M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $3.43M 10-Q · filed 2023-05-15 | $4.97M derived: sum of 2 quarters · filed 2023-05-15 | $6.17M derived: sum of 3 quarters · filed 2023-05-15 | $7.40M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.74M derived: sum of 2 quarters · filed 2023-03-24 | $3.97M derived: sum of 3 quarters · filed 2023-03-24 | $5.17M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.44M derived: sum of 2 quarters · filed 2022-11-14 | $3.63M 10-Q · filed 2022-11-14 | $5.61M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $2.43M 10-Q · filed 2022-08-22 | $4.41M derived: sum of 3 quarters · filed 2022-08-22 | $4.79M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-10 | $3.17M derived: sum of 2 quarters · filed 2022-05-10 | $3.56M derived: sum of 3 quarters · filed 2022-05-10 | $3.85M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.36M derived: sum of 2 quarters · filed 2022-03-11 | $2.66M derived: sum of 3 quarters · filed 2022-03-11 | $2.67M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17 | $679.00K derived: sum of 2 quarters · filed 2021-11-17 | $693.00K 10-Q · filed 2021-11-17 | $818.00K derived: sum of 4 quarters · filed 2021-11-17 | ||||
| 2020-06-30 | $295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $309.00K 10-Q · filed 2021-08-13 | $434.00K derived: sum of 3 quarters · filed 2021-08-13 | $1.59M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $14.00K 10-Q · filed 2021-05-17 | $139.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.29M derived: sum of 3 quarters · filed 2021-05-17 | $4.99M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.28M derived: sum of 2 quarters · filed 2021-03-31 | $4.98M derived: sum of 3 quarters · filed 2021-03-31 | $5.16M 10-K · filed 2021-03-31 | $5.16M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $4.85M derived: sum of 2 quarters · filed 2020-11-16 | $5.03M 10-Q · filed 2020-11-16 | $5.03M 10-Q · filed 2019-11-14 | $4.77M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $3.88M 10-Q · filed 2020-08-13 | $3.88M 10-Q · filed 2019-08-14 | $3.61M derived: sum of 3 quarters · filed 2020-08-13 | $4.26M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $178.00K 10-Q · filed 2020-05-15 | $178.18K 10-Q · filed 2019-05-21 | -$86.22K derived: sum of 2 quarters · filed 2020-05-15 | $556.99K derived: sum of 3 quarters · filed 2020-05-15 | $971.09K derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | -$264.22K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $378.99K derived: sum of 2 quarters · filed 2020-04-03 | $793.09K derived: sum of 3 quarters · filed 2020-04-03 | $1.20M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $643.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.06M derived: sum of 2 quarters · filed 2019-11-14 | $1.46M 10-Q · filed 2019-11-14 | $1.69M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $414.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $817.93K 10-Q · filed 2019-08-14 | $1.05M derived: sum of 3 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $403.82K 10-Q · filed 2019-05-21 | $636.29K derived: sum of 2 quarters · filed 2019-05-21 | ||||||
| 2017-12-31 | $232.47K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $600.36K 10-K · filed 2019-04-10 | ||||||
| 2017-09-30 | $367.89K 10-Q · filed 2018-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |